Biology subjects

Kleiner, D.

Publications and source records attributed to Kleiner, D..

6 recordsLinked to original sources

bioRxiv2026

A ratiometric biochemical framework reveals strain-specific metabolic allocation strategies in brook trout liver

Brook trout (Salvelinus fontinalis) exhibit strain-level variation in growth performance, environmental tolerance, and survival, yet the biochemical mechanisms underlying these differences remain poorly understood. We developed and applied a ratiometric biochemical framework integrating the pentose-phosphate pathway (PPP) and glutathione metabolism to characterize strain-specific hepatic metabolic organization in brook trout. Five strains reared under standardized conditions differed significantly in hepatic soluble protein density, glutathione pool size, total NADP(H) concentration, and activities of glucose-6-phosphate dehydrogenase (G6PDH), glutathione reductase (GR), and transketolase (TKT). These differences were not uniformly coordinated across pathways, demonstrating that metabolic phenotype cannot be inferred from individual biomarkers alone. Derived ratios describing oxidative-to-non-oxidative PPP capacity (G6PDH/TKT) and glutathione buffering relative to recycling capacity ((GSH+GSSG)/GR) resolved distinct patterns of metabolic allocation among strains. Despite shared ancestry, the Temiscamie (TEM) strain and its domestic x TEM hybrid (TXD) exhibited markedly divergent metabolic phenotypes, demonstrating that closely related strains can differ substantially in hepatic metabolic organization. Together, these findings identify relative allocation among interconnected metabolic pathways as an axis of physiologic diversity and establish a ratiometric approach for comparing metabolic organization across populations and species. Graphical abstractHepatic metabolic phenotypes of brook trout strains were characterized by integrating pentose phosphate pathway enzyme capacities, glutathione metabolism, NADP(H) availability, and soluble protein into a ratiometric framework. Ratios distinguish investment in oxidative versus non-oxidative PPP capacity (G6PDH/TKT), antioxidant buffering versus glutathione recycling capacity (total glutathione/GR), and hepatic protein density (soluble protein/liver mass), revealing distinct metabolic organization among strains. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=88 SRC="FIGDIR/small/743818v1_ufig1.gif" ALT="Figure 1"> View larger version (25K): org.highwire.dtl.DTLVardef@dc1b21org.highwire.dtl.DTLVardef@79528borg.highwire.dtl.DTLVardef@11a2805org.highwire.dtl.DTLVardef@398be9_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIA ratiometric framework was developed to characterize hepatic metabolic organization in brook trout C_LIO_LIGlutathione buffering and recycling capacity distinguish alternative redox phenotypes C_LIO_LIInvestment in oxidative and non-oxidative PPP capacity varies independently among strains C_LIO_LIG6PDH/TKT and total glutathione (GSH+GSSG)/GR reveal distinct metabolic phenotypes C_LIO_LIRatiometric indices provide a framework for interpreting redox metabolism and carbon allocation C_LI

biochemistry↗

bioRxiv2025

Metabolite correlation networks reveal complex phenotypes of adaptation-driving mutations

Living organisms are organized into hierarchical levels of increasing complexity. As mutational effects propagate through these levels, multiple phenotypes are produced. However, identifying which phenotypes influence fitness and drive selection remains a key challenge in understanding genotype-phenotype-fitness relationships. Here, we demonstrate that mutation-induced structural changes in metabolite correlation networks--an organizational level with emergent properties shaped by the cumulative effects of multiple biochemical reactions and regulatory mechanisms--constitute complex phenotypes linking mutations to bacterial fitness. We engineered a metabolically suboptimal E. coli strain by replacing the metK gene encoding methionine adenosyltransferase (MAT) with an ortholog from U. urealyticum and subjected it to laboratory evolution. Analysis of correlation networks constructed from 2,118 untargeted metabolites revealed that adaptive mutations enhanced the strains fitness by reducing network density, removing node hubs, and extensively rewiring connectivity. These changes yielded smaller, more cohesive, and better-interconnected network clusters. Moreover, evolution shifted the node representing S-adenosylmethionine (SAM), the product of the MAT-catalyzed reaction, from a peripheral role to a key connector between network clusters with a significantly increased betweenness. None of the accumulated mutations potentially driving this transition directly influenced MAT activity or SAM metabolism, indicating that the shift in SAMs role is an adaptive phenotype emerging from the metabolic systems complexity. Targeted metabolomics of key nodes displaying similar network transitions unveiled additional metabolites involved in SAM-related pathways. We propose the construction and analysis of metabolite correlation networks as an experimental and analytical framework for mapping genotype-phenotype-fitness relationships and exploring the mechanisms of metabolic adaptation.

evolutionary biology↗

bioRxiv2024

SARS-CoV-2 Infection of Salivary Glands Predisposes to Oral Candidiasis

Saliva contains antimicrobial peptides considered integral components of host innate immunity, and crucial for protection against colonizing microbial species. Most notable is histatin-5 which is exclusively produced in salivary glands with uniquely potent antifungal activity against the opportunistic pathogen Candida albicans. Recently, SARS-CoV-2 was shown to replicate in salivary gland acinar cells eliciting local immune cell activation. In this study, we performed mechanistic and clinical studies to investigate the implications of SARS-CoV-2 infection on salivary histatin-5 production and Candida colonization. Bulk RNA-sequencing of parotid salivary glands from COVID-19 autopsies demonstrated statistically significant decreased expression of histatin genes. In situ hybridization, coupled with immunofluorescence for co-localization of SARS-CoV-2 spike and histatin in salivary gland cells, showed that histatin was absent or minimally present in acinar cells with replicating viruses. To investigate the clinical implications of these findings, salivary histatin-5 levels and oral Candida burden in saliva samples from three independent cohorts of mild and severe COVID-19 patients and matched healthy controls were evaluated. Results revealed significantly reduced histatin-5 in SARS-CoV-2 infected subjects, concomitant with enhanced prevalence of C. albicans. Analysis of prospectively recovered samples indicated that the decrease in histatin-5 is likely reversible in mild-moderate disease as concentrations tended to increase during the post-acute phase. Importantly, salivary cytokine profiling demonstrated correlations between activation of the Th17 inflammatory pathway, changes in histatin-5 concentrations, and subsequent clearance of C. albicans in a heavily colonized subject. The importance of salivary histatin-5 in controlling the proliferation of C. albicans was demonstrated using an ex vivo assay where C. albicans was able to proliferate in COVID-19 saliva with low histatin-5, but not with high histatin-5. Taken together, the findings from this study provide direct evidence implicating SARS-CoV-2 infection of salivary glands with compromised oral innate immunity, and potential predisposition to oral candidiasis. AUTHOR SUMMARYSaliva contains antimicrobial peptides part of host innate immunity crucial for protection against colonizing microbial species. Most notable is the antifungal peptide histatin-5 produced in salivary glands cells. SARS-CoV-2 was shown to replicate in salivary gland cells causing tissue inflammation. In this study, we showed decreased expression of histatin genes in salivary glands from COVID-19 autopsies, and co-localization studies of SARS-CoV-2 spike and histatin revealed absence or minimal presence of histatin in acinar cells with replicating virus. To investigate the clinical implications of these findings, we conducted studies using saliva samples from subjects with mild to severe COVID-19, matched with healthy controls. Results revealed significantly reduced histatin-5 in SARS-CoV-2 infected subjects with enhanced prevalence of C. albicans. Prospective analysis indicated the decrease in histatin-5 is reversible in mild-moderate disease, and salivary cytokine profiling demonstrated activation of the Th17 inflammatory pathway. The importance of salivary histatin-5 in controlling the proliferation of C. albicans was demonstrated using an ex vivo assay where C. albicans was able to proliferate in saliva with low histatin-5, but not with high histatin-5. Collectively, the findings provide direct evidence implicating SARS-CoV-2 infection of salivary glands with compromised oral innate immunity and predisposition to oral candidiasis.

microbiology↗

bioRxiv2021

SAMase of bacteriophage T3 inactivates E. coli methionine S-adenosyltransferase by forming hetero-polymers

S-adenosylmethionine lyase (SAMase) of bacteriophage T3 degrades the intracellular SAM pools of the host E. coli cells, thus inactivating a crucial metabolite involved in plethora of cellular functions, including DNA methylation. SAMase is the first viral protein expressed upon infection and its activity prevents methylation of the T3 genome. Maintenance of the phage genome in a fully unmethylated state has a profound effect on the infection strategy -- it allows T3 to shift from a lytic infection under normal growth conditions to a transient lysogenic infection under glucose starvation. Using single-particle Cryo-EM and biochemical assays, we demonstrate that SAMase performs its function by not only degrading SAM, but also by interacting with and efficiently inhibiting the hosts methionine S-adenosyltransferase (MAT) -- the enzyme that produces SAM. Specifically, SAMase triggers open-ended head-to-tail assembly of E. coli MAT into an unusual linear filamentous structure in which adjacent MAT tetramers are joined together by two SAMase dimers. Molecular dynamics simulations together with normal mode analyses suggest that the entrapment of MAT tetramers within filaments leads to an allosteric inhibition of MAT activity due to a shift to low-frequency high-amplitude active site-deforming modes. The amplification of uncorrelated motions between active site residues weakens MATs ability to withhold substrates, explaining the observed loss of function. We propose that the dual function of SAMase as an enzyme that degrades SAM and as an inhibitor of MAT activity has emerged to achieve an efficient depletion of the intracellular SAM pools. IMPORTANCESelf-assembly of enzymes into filamentous structures in response to specific metabolic cues has recently emerged as a widespread strategy of metabolic regulation. In many instances filamentation of metabolic enzymes occurs in response to starvation and leads to functional inactivation. Here, we report that bacteriophage T3 modulates the metabolism of the host E. coli cells by recruiting a similar strategy -- silencing a central metabolic enzyme by subjecting it to phage-mediated polymerization. This observation points to an intriguing possibility that virus-induced polymerization of the host metabolic enzymes might be a common mechanism implemented by viruses to metabolically reprogram and subdue infected cells.

microbiology↗

bioRxiv2019

The inter-dimeric interface controls function and stability of Ureaplasma urealiticum methionine S-adenosyltransferase

Methionine S-adenosyltransferases (MATs) are predominantly homotetramers, comprised of dimers of dimers. The highly conserved dimeric interface harbors two active sites, making the dimer the obligatory functional unit. Yet, functionality of the recently evolved inter-dimeric interface remains unknown. Here, we show that the inter-dimeric interface of U. urealiticum MAT has evolved to control the catalytic activity and structural integrity of the homotetramer in response to product accumulation. When all four active sites are occupied with the product, S-adenosylmethionine (SAM), binding of four additional SAM molecules to the inter-dimeric interface prompts a [~]45{degrees} shift in the dimer orientation and a concomitant [~]60% increase in the interface area. This rearrangement inhibits the enzymatic activity by locking the flexible active site loops in a closed state and renders the tetramer resistant to proteolytic degradation. Our findings suggest that the inter-dimeric interfaces of MATs are recruited by evolution to tune the molecular properties of the entire homotetramer.

biochemistry↗

bioRxiv2018

Integrated proteogenomic analysis of metastatic thoracic tumors identifies APOBEC mutagenesis and copy number alterations as drivers of proteogenomic tumor evolution and heterogeneity

Elucidation of the proteogenomic evolution of metastatic tumors may offer insight into the poor prognosis of patients harboring metastatic disease. We performed whole-exome and transcriptome sequencing, copy number alterations (CNA) and mass spectrometry-based quantitative proteomics of 37 lung adenocarcinoma (LUAD) and thymic carcinoma (TC) metastases obtained by rapid autopsy and found evidence of patient-specific, multi-dimensional heterogeneity. Extreme mutational heterogeneity was evident in a subset of patients whose tumors showed increased APOBEC-signature mutations and expression of APOBEC3 region transcripts compared to patients with lesser mutational heterogeneity. TP53 mutation status was associated with APOBEC hypermutators in our cohort and in three independent LUAD datasets. In a thymic carcinoma patient, extreme heterogeneity and increased APOBEC3AB expression was associated with a high-risk germline APOBEC3AB variant allele. Patients with CNA occurring late in tumor evolution had corresponding changes in gene expression and protein abundance indicating genomic instability as a mechanism of downstream transcriptomic and proteomic heterogeneity between metastases. Across all tumors, proteomic heterogeneity was greater than copy number and transcriptomic heterogeneity. Enrichment of interferon pathways was evident both in the transcriptome and proteome of the tumors enriched for APOBEC mutagenesis despite a heterogeneous immune microenvironment across metastases suggesting a role for the immune microenvironment in the expression of APOBEC transcripts and generation of mutational heterogeneity. The evolving, heterogeneous nature of LUAD and TC, through APOBEC-mutagenesis and CNA illustrate the challenges facing treatment outcomes.

cancer biology↗